Lidocaine Hydrochloride Solution
NDC Package 71872-7357-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Lidocaine Hydrochloride solution is lidocaine Hydrochloride Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. This formulation utilizes a solution delivery system. Marketed by Medical Purchasing Solutions, Llc., this product is identified by NDC 71872-7357 and is authorized under FDA application ANDA212821.

Identification & Billing

NDC Package Code
71872-7357-1
Package Description
1 VIAL in 1 BAG / 5 mL in 1 VIAL
Product Code
11-Digit Billing Format
71872735701
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lidocaine Hydrochloride
Non-Proprietary Name
Lidocaine Hydrochloride
Substance Name
Lidocaine Hydrochloride
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Usage Information
Lidocaine Hydrochloride Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.

Regulatory & Marketing

Labeler Name
Medical Purchasing Solutions, Llc.
Product Type
Human Prescription Drug
FDA Application #
ANDA212821
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-15-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71872-7357-1 identifies a specific commercial package of 1 vial in 1 bag / 5 ml in 1 vial of Lidocaine Hydrochloride, a human prescription drug labeled by Medical Purchasing Solutions, Llc.. This solution is formulated for intravenous use and contains lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medical Purchasing Solutions, Llc. on June 15, 2023. The current certification is valid through December 31, 2026.

How is this Medical Purchasing Solutions, Llc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71872735701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71872-7357-1
11-Digit CMS (5-4-2)
71872-7357-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.